Daxor Profit Margin

The latest profit margin for DXR is 66818.86% as of December 2025. That compares with 27.14% in the prior-year period — up 246101.4% year over year. That is above the Healthcare sector average of 14.34%. Investors often review this figure alongside Daxor's historical trend and sector peers before judging valuation or financial health.

Over the past year, DXR's profit margin moved from 27.14% to 66818.86% — a 246101.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Daxor's valuation or profitability profile.

Against Healthcare companies, DXR currently prints 66818.86% for profit margin, while the sector average sits near 14.34%. That is roughly 465706.1% above the sector mean. Large gaps often invite a closer look at Daxor's growth, margins, and balance sheet.

Profit Margin shows how effectively Daxor converts resources into returns. At 66818.86%, DXR may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 27.14% in the prior-year period — up 246101.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting DXR's profit margin (66818.86%), review year-over-year change from 27.14%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.